CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 62 filers reported holding CIDARA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,111 | -16.6% | 17,100 | 0.0% | 0.00% | – |
Q2 2023 | $19,323 | -11.0% | 17,100 | 0.0% | 0.00% | – |
Q1 2023 | $21,717 | +67.9% | 17,100 | 0.0% | 0.00% | – |
Q4 2022 | $12,932 | +29.3% | 17,100 | 0.0% | 0.00% | – |
Q3 2022 | $10,000 | +25.0% | 17,100 | 0.0% | 0.00% | – |
Q2 2022 | $8,000 | -42.9% | 17,100 | 0.0% | 0.00% | – |
Q1 2022 | $14,000 | -33.3% | 17,100 | 0.0% | 0.00% | – |
Q4 2021 | $21,000 | -44.7% | 17,100 | 0.0% | 0.00% | – |
Q3 2021 | $38,000 | +11.8% | 17,100 | 0.0% | 0.00% | – |
Q2 2021 | $34,000 | -24.4% | 17,100 | 0.0% | 0.00% | – |
Q1 2021 | $45,000 | -70.2% | 17,100 | -72.3% | 0.00% | – |
Q1 2020 | $151,000 | +344.1% | 61,681 | +561.3% | 0.00% | – |
Q4 2019 | $34,000 | +3.0% | 9,327 | +22.7% | 0.00% | – |
Q3 2018 | $33,000 | -19.5% | 7,600 | -3.8% | 0.00% | – |
Q2 2018 | $41,000 | -54.9% | 7,900 | -65.2% | 0.00% | – |
Q1 2018 | $91,000 | -42.0% | 22,700 | 0.0% | 0.00% | – |
Q4 2017 | $157,000 | +124.3% | 22,700 | +164.0% | 0.00% | – |
Q3 2017 | $70,000 | +7.7% | 8,600 | 0.0% | 0.00% | – |
Q2 2017 | $65,000 | -62.4% | 8,600 | -46.6% | 0.00% | – |
Q4 2016 | $173,000 | – | 16,108 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
Prosight Management, LP | 245,764 | $578,000 | 0.30% |